Pfizer partnered with BioNTech to develop the Comirnaty vaccine, with Duality aiming to submit applications for US market entry.
3 reports, 3 independent
Updated Sep 6
Gone quiet
Reached 3 outlets in its first 24 hours
- Reports
- 3
- Developments
- 3
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pfizer partnered with BioNTech to develop the Comirnaty vaccine, with Duality aiming to submit applications for US market entry.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- BioNTech is undergoing leadership transitions and divestment, with revenue tied to its COVID-19 vaccine partnership with Pfizer.Sub-event
- BioNTech is facing performance issues leading to co-founders planning to leave the company by the end of 2026, with revenue dependent on the partnership with Pfizer.Sub-event
Pfizer partnered with BioNTech to develop the Comirnaty vaccine, aiming for US market entry via Duality.1 source
Keep exploring
The entities involved
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
-
DUALITY
Czech company
Nothing else this week.
-
Özlem Türeci
Turkish-German physician (born 1967)
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- Motley FoolWhy BioNTech Stock Crushed the Market Today The cancer drug BioNTech is developing with a China-based peer did well in a late-stage, head-to-head trial. The drug met its primary endpoint in the study
- BenzingaBioNTech Advances On Positive Phase 3 Breast Cancer Drug Data On Friday, BioNTech SE (NASDAQ:BNTX) and its partner Duality Biologics (Suzhou) Co., Ltd. released topline data from a Phase 3 trial in C
- CNW GroupPfizer Canada and BioNTech Receive Health Canada Approval of LP.8.1 Variant Adapted COVID-19 Vaccine LP.8.1 variant adapted COVID-19 vaccine COMIRNATY is now authorized in Canada for individuals 6 mo